Point-of-care blood glucose testing for diabetes care in hospitalized patients: An evidence-based review

Journal of Diabetes Science and Technology

Volumn 8, Issue 6, 2014, Pages 1081-1090

  Rajendran, Rajesh ^a   Rayman, Gerry ^a  

^a IPSWICH HOSPITAL NHS TRUST   (United Kingdom)

Author keywords

Blood glucose; Blood glucose meter; Diabetes; Hospital; Inpatients; Point of care

Indexed keywords

GLUCOSE; GLUCOSE BLOOD LEVEL;

BLOOD GLUCOSE METER; BLOOD GLUCOSE MONITORING; BLOOD SAMPLING; CONTINUOUS GLUCOSE MONITORING; COST EFFECTIVENESS ANALYSIS; CROSS INFECTION; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HOSPITAL PATIENT; HUMAN; MEASUREMENT ACCURACY; NONINVASIVE GLUCOSE MONITORING; POINT OF CARE TESTING; QUALITY CONTROL; REVIEW; STAFF TRAINING; ANALYSIS; COST BENEFIT ANALYSIS; ECONOMICS; EVIDENCE BASED MEDICINE; HOSPITAL; HOSPITAL INFORMATION SYSTEM;

BLOOD GLUCOSE; COST-BENEFIT ANALYSIS; EVIDENCE-BASED MEDICINE; HOSPITALS; HUMANS; INPATIENTS; POINT-OF-CARE SYSTEMS;

EID: 84937892924     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/1932296814538940     Document Type: Review

References (112)

1. American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2013;36(4):1033-1046.
2. Kanavos P, van den Aardweg S, Schurer W. Diabetes expenditure, burden of disease and management in 5 EU countries 2012. Available at: http://www.lse.ac.uk/LSEHealthAndSocialCare/research/LSEHealth/MTRG/ResearchReportOnDiabetes.aspx.
3. Baker ST, Chiang CY, Zajac JD, Bach LA, Jerums G, MacIsaac RJ. Outcomes for general medical inpatients with diabetes mellitus and new hyperglycaemia. Med J Australia. 2008;188(6):340-343.
4. Brodovicz KG, Mehta V, Zhang Q, et al. Association between hypoglycemia and inpatient mortality and length of hospital stay in hospitalized, insulin-treated patients. Curr Med Res Opin. 2013;29(2):101-107.
5. Garg R, Hurwitz S, Turchin A, Trivedi A. Hypoglycemia, with or without insulin therapy, is associated with increased mortality among hospitalized patients. Diabetes Care. 2013;36(5):1107-1110.
6. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc. 2003;78(12):1471-1478.
7. Krinsley J, Schultz MJ, Spronk PE, et al. Mild hypoglycemia is strongly associated with increased intensive care unit length of stay. Ann Intensive Care. 2011;1:49.
8. Krinsley JS, Schultz MJ, Spronk PE, et al. Mild hypoglycemia is independently associated with increased mortality in the critically ill. Crit Care. 2011;15(4):R173.
9. Nirantharakumar K, Marshall T, Kennedy A, Narendran P, Hemming K, Coleman JJ. Hypoglycaemia is associated with increased length of stay and mortality in people with diabetes who are hospitalized. Diabetic Med. 2012;29(12):e445- 448.
10. Turchin A, Matheny ME, Shubina M, Scanlon JV, Greenwood B, Pendergrass ML. Hypoglycemia and clinical outcomes in patients with diabetes hospitalized in the general ward. Diabetes Care. 2009;32(7):1153-1157.
11. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of inhospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87(3):978-982.
12. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345(19):1359-1367.
13. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354(5):449-461.
14. American Diabetes Association. Standards of medical care in diabetes-2008. Diabetes Care. 2008;31(suppl 1):S12-S54.
15. Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283-1297.
16. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA. 2008;300(8):933-944.
17. Griesdale DE, de Souza RJ, van Dam RM, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ. 2009;180(8):821-827.
18. American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes Care. 2013;36(suppl 1):S11-S66.
19. ISO22870:2006. Point-of-care testing (POCT)-requirements for quality and competence Geneva: International Organization for Standardization; 2006. Available at: http://www.iso.org/iso/catalogue-detail.htm?csnumber=35173.
20. Clarke SF, Foster JR. A history of blood glucose meters and their role in self-monitoring of diabetes mellitus. Br J Biomed Sci. 2012;69(2):83-93.
21. Johnson G. Clinical lecture on the various modes of testing for sugar in the urine. BMJ. 1884;1(1201):1-4.
22. Benedict SR. A reagent for the detection of reducing sugars. 1908. J Biol Chem. 2002;277(16):e5.
23. Free AH, Adams EC, Kercher ML, Free HM, Cook MH. Simple specific test for urine glucose. Clin Chem. 1957;3(3):163-168.
24. Kohn J. A rapid method of estimating blood-glucose ranges. Lancet. 1957;273(6986):119-121.
25. Free AH, Free HM. Self testing, an emerging component of clinical chemistry. Clin Chem. 1984;30(6):829-838.
26. Mendosa D. History of blood glucose meters: transcripts of interviews 2006. Available at: http://www.mendosa.com/history.htm.
27. BCCResearch. Point of Care Diagnostics (Report code HLC043C) BCC Research; 2012. Available at: http://www.bccresearch.com/market-research/healthcare/point-of-carediagnostics-market-hlc043c.html.
28. Schimke I. Quality and timeliness in medical laboratory testing. Analy Bioanal Chem. 2009;393(5):1499-1504.
29. Louie RF, Tang Z, Shelby DG, Kost GJ. Point-of-care testing: millennium technology for critical care. Lab Med. 2000;31(7):402-408.
30. Howanitz PJ, Jones BA, College of American P. Comparative analytical costs of central laboratory glucose and bedside glucose testing: a College of American Pathologists Q-Probes study. Arch Pathol Lab Med. 2004;128(7):739-745.
31. Hawkins RC. Laboratory turnaround time. Clin Biochem Rev. 2007;28(4):179-194.
32. Blick KE. The essential role of information management in point-of-care/critical care testing. Clin Chim Acta. 2001;307(1-2):159-168.
33. Kilgore ML, Steindel SJ, Smith JA. Evaluating stat testing options in an academic health center: therapeutic turnaround time and staff satisfaction. Clin Chem. 1998;44(8 pt 1):1597-1603.
34. Wisser D, van Ackern K, Knoll E, Wisser H, Bertsch T. Blood loss from laboratory tests. Clin Chem. 2003;49(10):1651-1655.
35. Branco BC, Inaba K, Doughty R, et al. The increasing burden of phlebotomy in the development of anaemia and need for blood transfusion amongst trauma patients. Injury. 2012;43(1):78-83.
36. Smoller BR, Kruskall MS. Phlebotomy for diagnostic laboratory tests in adults. Pattern of use and effect on transfusion requirements. N Engl J Med. 1986;314(19):1233-1235.
37. Page C, Retter A, Wyncoll D. Blood conservation devices in critical care: a narrative review. Ann Intensive Care. 2013;3(1):14.
38. Da Rin G. Pre-analytical workstations: a tool for reducing laboratory errors. Clin Chim Acta. 2009;404(1):68-74.
39. Kiechle FL, Main RI. Blood glucose: measurement in the point-of-care setting. Lab Med. 2000;31(5):276-282.
40. O'Kane MJ, McManus P, McGowan N, Lynch PL. Quality error rates in point-of-care testing. Clin Chem. 2011;57(9):1267-1271.
41. Nichols JH. Blood glucose testing in the hospital: error sources and risk management. J Diabetes Sci Technol. 2011;5(1):173-177.
42. Carraro P, Plebani M. Post-analytical errors with portable glucose meters in the hospital setting. Clin Chim Acta. 2009;404(1):65-67.
43. Plebani M. Does POCT reduce the risk of error in laboratory testing? Clin Chim Acta. 2009;404(1):59-64.
44. Dungan K, Chapman J, Braithwaite SS, Buse J. Glucose measurement: confounding issues in setting targets for inpatient management. Diabetes Care. 2007;30(2):403-409.
45. Rebel A, Rice MA, Fahy BG. Accuracy of point-of-care glucose measurements. J Diabetes Sci Technol. 2012;6(2):396-411.
46. Pitkin AD, Rice MJ. Challenges to glycemic measurement in the perioperative and critically ill patient: a review. J Diabetes Sci Technol. 2009;3(6):1270-1281.
47. Wahl HG. How accurately do we measure blood glucose levels in intensive care unit (ICU) patients? Best practice & research. Clin Anaesth. 2009;23(4):387-400.
48. D'Orazio P, Burnett RW, Fogh-Andersen N, et al. Approved IFCC recommendation on reporting results for blood glucose (abbreviated). Clin Chem. 2005;51(9):1573-1576.
49. Flore KM, Delanghe JR. Analytical interferences in pointof- care testing glucometers by icodextrin and its metabolites: an overview. Perit Dial Int. 2009;29(4):377-383.
50. US Food and Drug Administration. FDA public health notification: potentially fatal errors with GDH-PQQ∗ glucose monitoring technology. US Food and Drug Administration; 2009. Available at: http://www.fda.gov/%20MedicalDevices/Safety/AlertsandNotices/PublicHealthNotifications/ucm176992.htm.
51. Olansky L, Kennedy L. Finger-stick glucose monitoring: issues of accuracy and specificity. Diabetes Care. 2010;33(4):948-949.
52. Perera NJ, Stewart PM, Williams PF, Chua EL, Yue DK, Twigg SM. The danger of using inappropriate point-of-care glucose meters in patients on icodextrin dialysis. Diabetic Med. 2011;28(10):1272-1276.
53. Inoue S, Egi M, Kotani J, Morita K. Accuracy of bloodglucose measurements using glucose meters and arterial blood gas analyzers in critically ill adult patients: systematic review. Crit Care. 2013;17(2):R48.
54. American Diabetes Association. Consensus statement on self-monitoring of blood glucose. Diabetes Care. 1987;10(1):95-99.
55. American Diabetes Association. Sell-monitoring of blood glucose. Diabetes Care. 1996;19(suppl 1):S62-S66.
56. ISO15197:2003. Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus. Geneva, Switzerland: International Organization for Standardization; 2003. Available at: http://www.iso.org/iso/catalogue-detail?csnumber=26309.
57. ISO15197:2013. Requirements for blood glucose monitoring systems for self-testing in managing diabetes mellitus. Geneva, Switzerland: International Organization for Standardization; 2013. Available at: http://www.iso.org/iso/home/store/catalogue-tc/catalogue-detail.htm?csnumber=54976.
58. Clinical and Laboratory Standards Institute. Point-of-care blood glucose testing in acute and chronic care facilities; approved guideline-third edition 2013. Available at: http://www.clsi.org/standards/.
59. Krouwer JS, Cembrowski GS. A review of standards and statistics used to describe blood glucose monitor performance. J Diabetes Sci Technol. 2010;4(1):75-83.
60. Freckmann G, Baumstark A, Jendrike N, et al. System accuracy evaluation of 27 blood glucose monitoring systems according to DIN EN ISO 15197. Diabetes Technol Ther. 2010;12(3):221-231.
61. Freckmann G, Schmid C, Baumstark A, Pleus S, Link M, Haug C. System accuracy evaluation of 43 blood glucose monitoring systems for self-monitoring of blood glucose according to DIN EN ISO 15197. J Diabetes Sci Technol. 2012;6(5):1060-1075.
62. Robinson CS, Sharp P. Tighter accuracy standards within point-of-care blood glucose monitoring: how six commonly used systems compare. J Diabetes Sci Technol. 2012;6(3): 547-554.
63. Kuo CY, Hsu CT, Ho CS, Su TE, Wu MH, Wang CJ. Accuracy and precision evaluation of seven self-monitoring blood glucose systems. Diabetes Technol Ther. 2011;13(5):596-600.
64. Gijzen K, Moolenaar DL, Weusten JJ, Pluim HJ, Demir AY. Is there a suitable point-of-care glucose meter for tight glycemic control? Evaluation of one home-use and four hospitaluse meters in an intensive care unit. Clin Chem Lab Med. 2012;50(11):1985-1992.
65. Brazg RL, Klaff LJ, Parkin CG. Performance variability of seven commonly used self-monitoring of blood glucose systems: clinical considerations for patients and providers. J Diabetes Sci Technol. 2013;7(1):144-152.
66. Walsh J, Roberts R, Vigersky RA, Schwartz F. New criteria for assessing the accuracy of blood glucose monitors meeting, October 28, 2011. J Diabetes Sci Technol. 2012;6(2):466-474.
67. European Association for the Study of Diabetes. Medical devices in diabetes care: a statement on behalf of the European Association for the Study of Diabetes 2013. Available at: http://www.easd.org/images/easdwebfiles/statements/Medical-Devices-Statement.pdf.
68. American Diabetes Association. Statement by the American Diabetes Association on the need for FDA regulation of blood glucose test strips 2013. Available at: https://professional.diabetes.org/News-Display.aspx?CID=93129&TYP=9.
69. Klonoff DC, Reyes JS. Do currently available blood glucose monitors meet regulatory standards? 1-day public meeting in Arlington, Virginia. J Diabetes Sci Technol. 2013;7(4):1071-1083.
70. Thompson ND, Perz JF. Eliminating the blood: ongoing outbreaks of hepatitis B virus infection and the need for innovative glucose monitoring technologies. J Diabetes Sci Technol. 2009;3(2):283-288.
71. Thompson ND, Schaefer MK. "Never events": hepatitis B outbreaks and patient notifications resulting from unsafe practices during assisted monitoring of blood glucose, 2009- 2010. J Diabetes Sci Technol. 2011;5(6):1396-1402.
72. National Audit Office. Reducing healthcare associated infections in hospitals in England 2009. Available at: http://www.nao.org.uk/wp-content/uploads/2009/06/0809560es.pdf.
73. Scott DR. The direct medical costs of healthcare-associated infections in U.S. hospitals and the benefits of prevention 2009. Available at: http://www.cdc.gov/hai/pdfs/hai/scott-costpaper.pdf.
74. Louie RF, Lau MJ, Lee JH, Tang Z, Kost GJ. Multicenter study of the prevalence of blood contamination on point-ofcare glucose meters and recommendations for controlling contamination. Point of Care. 2005;4(4):158-163.
75. Ng R, Koo S, Johnston R. Multicenter evaluation of bacterial contamination of glucose test strips. Clin Chim Acta. 2012;413(19-20):1485-1487.
76. Vanhaeren S, Duport C, Magneney M, et al. Bacterial contamination of glucose test strips: not to be neglected. Am J Infect Control. 2011;39(7):611-613.
77. Perez-Ayala M, Oliver P, Rodriguez Cantalejo F. Prevalence of bacterial contamination of glucose test strips in individual single-use packets versus multiple-use vials. J Diabetes Sci Technol. 2013;7(4):854-862.
78. US Food and Drug Administration. Use of fingerstick devices on more than one person poses risk for transmitting bloodborne pathogens: initial communication: update 29/11/2010. Available at: http://www.fda.gov/medicaldevices/safety/alertsandnotices/ucm224025.htm.
79. Centers for Disease Control and Prevention. Diabetes and viral hepatitis: important information on glucose monitoring. Centers for Disease Control and Prevention; 2012. Available at: http://www.cdc.gov/hepatitis/Settings/GlucoseMonitoring.htm.
80. Nichols JH. Estimated strip wastage from glucose meter infection control recommendations. Clin Chim Acta. 2012;414: 91-92.
81. Corl DE, Yin TS, Hoofnagle AN, Whitney JD, Hirsch IB, Wisse BE. The impact of inpatient point-of-care blood glucose quality control testing. J Healthcare Qual. 2012;34(4):24-32.
82. Kost GJ. Connectivity. The millennium challenge for pointof- care testing. Arch Pathol Lab Med. 2000;124(8):1108-1110.
83. Clinical and Laboratory Standards Institute. Point-of-care connectivity; approved standard. 2nd ed. 2006. Available at: http://www.clsi.org/standards/.
84. Salka L, Kiechle FL. Connectivity for point-of-care glucose testing reduces error and increases compliance. Point of Care. 2003;2(2):114-118.
85. Kim JY, Lewandrowski K. Point-of-care testing informatics. Clin Lab Med. 2009;29(3):449-461.
86. Goldberg PA, Bozzo JE, Thomas PG, et al. "Glucometrics"- assessing the quality of inpatient glucose management. Diabetes Technol Ther. 2006;8(5):560-569.
87. Bersoux S, Cook CB, Kongable GL, Shu J. Trends in glycemic control over a 2-year period in 126 US hospitals. J Hosp Med. 2013;8(3):121-125.
88. Cook CB, Moghissi E, Joshi R, Kongable GL, Abad VJ. Inpatient point-of-care bedside glucose testing: preliminary data on use of connectivity informatics to measure hospital glycemic control. Diabetes Technol Ther. 2007;9(6): 493-500.
89. Boaz M, Landau Z, Matas Z, Wainstein J. Institutional blood glucose monitoring system for hospitalized patients: an integral component of the inpatient glucose control program. J Diabetes Sci Technol. 2009;3(5):1168-1174.
90. Thomas P, Inzucchi SE. An internet service supporting quality assessment of inpatient glycemic control. J Diabetes Sci Technol. 2008;2(3):402-408.
91. Nirantharakumar K, Chen YF, Marshall T, Webber J, Coleman JJ. Clinical decision support systems in the care of inpatients with diabetes in non-critical care setting: systematic review. Diabetic Med. 2012;29(6):698-708.
92. Kerry C, Mitchell S, Sharma S, Scott A, Rayman G. Diurnal temporal patterns of hypoglycaemia in hospitalized people with diabetes may reveal potentially correctable factors. Diabetic Med. 2013;30(12):1403-1406.
93. Lee-Lewandrowski E, Laposata M, Eschenbach K, et al. Utilization and cost analysis of bedside capillary glucose testing in a large teaching hospital: implications for managing point of care testing. Am J Med. 1994;97(3):222-230.
94. Greendyke RM. Cost analysis. Bedside blood glucose testing. Am J Clin Pathol. 1992;97(1):106-107.
95. Winkelman JW, Wybenga DR, Tanasijevic MJ. The fiscal consequences of central vs distributed testing of glucose. Clin Chem. 1994;40(8):1628-1630.
96. Nosanchuk JS, Keefner R. Cost analysis of point-of-care laboratory testing in a community hospital. Am J Clin Pathol. 1995;103(2):240-243.
97. Lum G. Assessment of a critical limit protocol for point-ofcare glucose testing. Am J Clin Pathol. 1996;106(3):390-395.
98. Hortin GL. Does point-of-care testing save money or cost more? Lab Med. 2005;36(8):465-467.
99. The National Academy of Clinical Biochemistry. Laboratory medicine practice guidelines: Evidence-based practice for point-of-care testing 2006. Available at: http://www.aacc.org/members/nacb/LMPG/OnlineGuide/PublishedGuidelines/poct/Pages/poctpdf.aspx.
100. Holzinger U, Warszawska J, Kitzberger R, et al. Real-time continuous glucose monitoring in critically ill patients: a prospective randomized trial. Diabetes Care. 2010;33(3):467-472.
101. Schierenbeck F, Franco-Cereceda A, Liska J. Evaluation of a continuous blood glucose monitoring system using central venous microdialysis. J Diabetes Sci Technol. 2012;6(6):1365-1371.
102. Brunner R, Kitzberger R, Miehsler W, Herkner H, Madl C, Holzinger U. Accuracy and reliability of a subcutaneous continuous glucose-monitoring system in critically ill patients. Crit Care Med. 2011;39(4):659-664.
103. Holzinger U, Warszawska J, Kitzberger R, Herkner H, Metnitz PG, Madl C. Impact of shock requiring norepinephrine on the accuracy and reliability of subcutaneous continuous glucose monitoring. Intensive Care Med. 2009;35(8):1383-1389.
104. Jacobs B, Phan K, Bertheau L, Dogbey G, Schwartz F, Shubrook J. Continuous glucose monitoring system in a rural intensive care unit: a pilot study evaluating accuracy and acceptance. J Diabetes Sci Technol. 2010;4(3):636-644.
105. Rabiee A, Andreasik V, Abu-Hamdah R, et al. Numerical and clinical accuracy of a continuous glucose monitoring system during intravenous insulin therapy in the surgical and burn intensive care units. J Diabetes Sci Technol. 2009;3(4):951-959.
106. Kalmovich B, Bar-Dayan Y, Boaz M, Wainstein J. Continuous glucose monitoring in patients undergoing cardiac surgery. Diabetes Technol Ther. 2012;14(3):232-238.
107. Joseph JI, Hipszer B, Mraovic B, Chervoneva I, Joseph M, Grunwald Z. Clinical need for continuous glucose monitoring in the hospital. J Diabetes Sci Technol. 2009;3(6):1309-1318.
108. Klonoff DC, Buckingham B, Christiansen JS, et al. Continuous glucose monitoring: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(10):2968-2979.
109. Blevins TC, Bode BW, Garg SK, et al. Statement by the American Association of Clinical Endocrinologists Consensus Panel on continuous glucose monitoring. Endocr Pract. 2010;16(5):730-745.
110. Rabinovitch B, March WF, Adams RL. Noninvasive glucose monitoring of the aqueous humor of the eye: Part I. Measurement of very small optical rotations. Diabetes Care. 1982;5(3):254-258.
111. Vashist SK. Non-invasive glucose monitoring technology in diabetes management: a review. Anal Chim Acta. 2012;750(0):16-27.
112. Ciudin A, Hernandez C, Simo R. Non-invasive methods of glucose measurement: current status and future perspectives. Curr Diabetes Rev. 2012;8(1):48-54.